Search research articles
Contact Us
Filters
Showing results (201-210 of 248) with videos related to
Page
of 25
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 18, 2022
The Effect of Regularly Dosed Acetaminophen vs No Acetaminophen on Renal Function in Plasmodium knowlesi Malaria (PACKNOW): A Randomized, Controlled Trial
Daniel J Cooper, Matthew J Grigg, Katherine Plewes, et al.
Nature Communications
|
April 7, 2023
Safe drugs with high potential to block malaria transmission revealed by a spleen-mimetic screening
Mario Carucci, Julien Duez, Joel Tarning, et al.
Antimicrobial Agents and Chemotherapy
|
August 16, 2021
Determinants of Primaquine and Carboxyprimaquine Exposures in Children and Adults with Plasmodium vivax Malaria
Cindy S Chu, James A Watson, Aung Pyae Phyo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 13, 2025
Pharmacometric evaluation of sulfadoxine-pyrimethamine- amodiaquine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda
Craig Bonnington, Anthony Nuwa, Katherine Theiss-Nyland, et al.
NPJ Vaccines
|
July 6, 2024
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults
Borimas Hanboonkunupakarn, Mavuto Mukaka, Podjanee Jittamala, et al.
Ebiomedicine
|
July 14, 2022
Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2
Jean-Sélim Driouich, Maxime Cochin, Franck Touret, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 24, 2012
Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria
Debashish Das, Rupam Tripura, Aung Pyae Phyo, et al.
The Lancet. Microbe
|
September 11, 2025
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials
James A Watson, Cintia Cruz, Fabiana Barreira, et al.
The Lancet. Infectious Diseases
|
December 24, 2024
Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial
Richard Idro, Thandile Nkosi-Gondwe, Robert Opoka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 6, 2019
Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
Cindy S Chu, Aung Pyae Phyo, Claudia Turner, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 248) with videos related to
Sort By:
Page
of 25
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 18, 2022
The Effect of Regularly Dosed Acetaminophen vs No Acetaminophen on Renal Function in Plasmodium knowlesi Malaria (PACKNOW): A Randomized, Controlled Trial
Daniel J Cooper, Matthew J Grigg, Katherine Plewes, et al.
Nature Communications
|
April 7, 2023
Safe drugs with high potential to block malaria transmission revealed by a spleen-mimetic screening
Mario Carucci, Julien Duez, Joel Tarning, et al.
Antimicrobial Agents and Chemotherapy
|
August 16, 2021
Determinants of Primaquine and Carboxyprimaquine Exposures in Children and Adults with Plasmodium vivax Malaria
Cindy S Chu, James A Watson, Aung Pyae Phyo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 13, 2025
Pharmacometric evaluation of sulfadoxine-pyrimethamine- amodiaquine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda
Craig Bonnington, Anthony Nuwa, Katherine Theiss-Nyland, et al.
NPJ Vaccines
|
July 6, 2024
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults
Borimas Hanboonkunupakarn, Mavuto Mukaka, Podjanee Jittamala, et al.
Ebiomedicine
|
July 14, 2022
Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2
Jean-Sélim Driouich, Maxime Cochin, Franck Touret, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 24, 2012
Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria
Debashish Das, Rupam Tripura, Aung Pyae Phyo, et al.
The Lancet. Microbe
|
September 11, 2025
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials
James A Watson, Cintia Cruz, Fabiana Barreira, et al.
The Lancet. Infectious Diseases
|
December 24, 2024
Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial
Richard Idro, Thandile Nkosi-Gondwe, Robert Opoka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 6, 2019
Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
Cindy S Chu, Aung Pyae Phyo, Claudia Turner, et al.
Page
of 25